Visit: 60 Corporate Woods, Suite 380 | Email: URVenturesInfo@urmc.rochester.edu | Phone: 585-276-6600
Want to further your understanding around IP, entrepreneurship and commercialization? URventures has compiled a list of educational resources to help you get started! We will be routinely updating and adding to this list, and welcome your feedback.
National high priority program funds two projects to better understand how coronavirus interacts with proteins in human cells. Two members of the University of Rochester’s Department of Biology have received expedited funding awards from the National Science Foundation (NSF) to study biological processes involved in
As part of the Jeff Lawrence Innovation Fund, FuzeHub will hold its fourth New York State Commercialization Competition on November 18 & 19, 2020. Companies will compete either in person or virtually to demonstrate the commercialization potential of their technology or product and can win
ROCHESTER, N.Y., June 12, 2020 – Employers across the country can advance reopening efforts with technology developed by the University of Rochester to check employees for potential COVID-19 symptoms before they report to work each day. Software code at the heart of a “Dr. Chatbot” screening tool, first
May 27, 2020 Lindsey Valich / lvalich@ur.rochester.edu A person who has a stroke that causes vision loss is often told there is nothing they can do to improve or regain the vision they have lost. But research from the University of Rochester, published in the journal Brain, may
Once again, the University of Rochester ranked among the top 100 worldwide universities granted U.S. utility patents in 2019, according to a report by the National Academy of Inventors (NAI) and the Intellectual Property Owners Association (IPO). Published annually since 2013, the report ranks the
The city of Rochester and Monroe County have partnered with Common Ground Health to roll out ROC COVID, an online symptom tracker for community residents. Developed by scientists and information technology staff at the University of Rochester Medical Center and Rochester Regional Health, the health
A new study shows that when specific human brain cells are transplanted into animal models of multiple sclerosis and other white matter diseases, the cells repair damage and restore function. The study provides one of the final pieces of scientific evidence necessary to advance this
The University of Rochester Medical Center has been participating in a clinical trial testing the safety and efficacy of the antiviral drug remdesivir. According to preliminary results released by the National Institutes of Health, the drug is now showing promise in treating adults diagnosed with COVID-19. The study is led by
Given the changing circumstances due to the Covid-19 pandemic, URVentures has decided to cancel the Spring 2020 round of the Technology Development Fund. Please direct any questions to the Fund’s Director. Omar Bakht Fund Director Omar_Bakht@urmc.rochester.edu
Apply to the New York Business Plan Competition by Noon on March 25 The Finger Lakes Region of the New York Business Plan Competition is accepting applications now through Wednesday, March 25, at noon (12:00 PM). Student teams attending colleges and universities in the Finger
The NSF I-Corps Upstate New York (UNY) Node is offering a short course program for researchers interested in exploring the market potential of their work and learning entrepreneurial skills. Short Courses—geared toward faculty, doctoral candidates, and postdocs—are offered at no cost to participants and consist
CNY Biotech Accelerator, a division of the State University of New York Upstate Medical University, located in Syracuse, NY, is seeking medical device innovators for its annual 6-month grant-funded Medical Device Innovation Challenge (MDIC). Applications from US-based innovators are accepted January 1 – May 31,
The University of Rochester has joined together with the University of Buffalo and Roswell Park Comprehensive Cancer Center to form Empire Discovery Institute, a new drug discovery partnership. EDI aims to convert the institutions’ scientific breakthroughs into viable pharmaceuticals for commercialization and to strengthen the
A new needle-free flu vaccine patch revved up the immune system much like a traditional flu shot without any negative side effects, according to a study published in the Journal of Investigative Dermatology. Though the research is in the early stages (the patch hasn’t been tested in
Oscine Therapeutics, a new biotechnology company based on discoveries made and developed at the University of Rochester Medical Center (URMC) has received a significant multi-year investment to support both research and development of cell-based therapies for neurological disorders. The funding represents the largest-ever investment in